Paid Clinical Trials in Park Ridge, IL
As of September 2026, 96 paid clinical trials are recruiting in Park Ridge, Illinois. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Park Ridge offers studies at sites including Advocate Lutheran General Hospital for conditions such as Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Park Ridge
Trials by drug in Park Ridge
Filter results
Newly added in Park Ridge
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
94 clinical trials
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
SELUTION4BTK Trial
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
The Pivotal Study of RapidPulseTM Aspiration System
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
COPD Exacerbation Follow Up
Examination of Nociscan Impact on Low Back Pain Surgical Outcomes
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Endotype DIrected Treatment for OSA in Down Syndrome
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Top Research Study Locations in Park Ridge
Researchers run research studies in Park Ridge, IL at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Advocate Lutheran General Hospital | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 55 |
| Advocate Children's Hospital-Park Ridge | B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ganglioneuroblastoma, Nodular | 15 |
| Advocate Aurora Research Institute | Acute Ischemic Stroke, Low Back Pain, Stroke Hemorrhagic | 3 |
| AMR Park Ridge | Heart Failure | 2 |
| Advocate Aurora Health | Cerebral Aneurysms, Metastatic Non Small Cell Lung Cancer | 2 |
| Advocate Children's Hospital | Hemolytic Disease of the Fetus and Newborn, Thrombocytopenia, Neonatal Alloimmune | 2 |
| Advocate Children's Hospital Park Ridge | Crohn's Disease, Crohn's Disease (CD), Ulcerative Colitis | 2 |
| Advocate Health | Acute Ischemic Stroke From Large Vessel Occlusion, Carotid Artery Calcification, Carotid Artery Diseases | 2 |
| Advocate Lutheran General Childrens Hospital | Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Disease and Lipoprotein(a) | 2 |
| Advocate Medical Group Adult Down Syndrome Center | Down Syndrome, Alzheimer Disease, Dementia | 2 |
| Advocate Aurora Lutheran General Hospital | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| Advocate Children's Hospital - Park Ridge - PIN | Crohn's Disease, Ulcerative Colitis | 1 |
| Advocate Lutheran General | Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 1 |
| Advocate Lutheran General Hospital (Advocate Children's Hospital - Park Ridge) | Infant and Young Child Feeding | 1 |
| Advocate Medical Group Oncology | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Alliance for Multispecialty Research LLC - Park Ridge | Cardiovascular Disease | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Local Institution - 0101 | Colitis, Ulcerative | 1 |
| Midwestern Regional Medical Center, Inc.City of Hope Chicago | Relapsed and/or Refractory B-cell Lymphoma | 1 |
Active & Upcoming Studies in Park Ridge (2026)
Recruiting trials in Park Ridge grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (55 active studies)
- Prevention of Oral Mucositis in Adults in With Hematologic Malignancy · Wake Forest University Health Sciences
- A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4) · Phase 3 · AstraZeneca
Neurology & pain (8 active studies)
- The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms · phenox Inc.
- Endotype DIrected Treatment for OSA in Down Syndrome · Phase 4 · University of Arizona
Cardiovascular (5 active studies)
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart · Phase 3 · Boehringer Ingelheim
Pediatric (2 active studies)
- Standardized Application of Feeding Evaluations Using SMART Tool · Wake Forest University Health Sciences
- A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) · Phase 3 · Janssen Research & Development, LLC
Common conditions studied in Park Ridge
- Acute Myeloid Leukemia (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Acute Lymphoblastic Leukemia (3 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
Leading research sponsors in Park Ridge
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- NRG Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Park Ridge?
There are approximately 96 recruiting clinical trials in Park Ridge, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Park Ridge pay participants?
Most recruiting trials in Park Ridge compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Park Ridge?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Park Ridge?
The most common conditions under active study in Park Ridge include Acute Myeloid Leukemia (5), Malignant Solid Neoplasm (5), Anatomic Stage II Breast Cancer AJCC v8 (4), Stage IV Lung Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Park Ridge?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Park Ridge on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Park Ridge?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Park Ridge?
Recruiting research sites in Park Ridge include Advocate Lutheran General Hospital, Advocate Children's Hospital-Park Ridge, Advocate Aurora Research Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Park Ridge right now?
The largest active categories in Park Ridge are Cancer & tumors (55), Neurology & pain (8), Cardiovascular (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.